AC
NASDAQ · ACRV
Acrivon Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$1.88
Up+$0.02 (+1.08%)
Updated Oct 8, 2026, 3:12 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.65M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $1.27 – $2.39
- Volume
- 283.46K
- Avg. volume
- 1.62M
Price performance · ACRV
ACRV price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
ACRV closed at $1.88 after 21 trading sessions, down 5.53% for the selected period.
- Last close
- $1.88
- Period change
- -5.53%
- Period low
- $1.70
- Period high
- $2.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $1.85 | $1.9133 | $1.82 | $1.88 | 283.46K |
| Oct 6, 2026 | $2.00 | $2.07 | $1.85 | $1.86 | 158.75K |
| Oct 5, 2026 | $1.99 | $2.035 | $1.91 | $1.98 | 402.17K |
| Oct 2, 2026 | $2.05 | $2.06 | $1.99 | $1.99 | 205.12K |
| Oct 1, 2026 | $2.02 | $2.12 | $2.00 | $2.01 | 316.87K |
| Sep 30, 2026 | $2.09 | $2.16 | $2.04 | $2.05 | 176.93K |
| Sep 29, 2026 | $2.05 | $2.12 | $2.05 | $2.08 | 132.7K |
| Sep 28, 2026 | $2.08 | $2.12 | $2.025 | $2.06 | 231.03K |
| Sep 25, 2026 | $2.12 | $2.13 | $2.07 | $2.10 | 181.95K |
| Sep 24, 2026 | $2.10 | $2.15 | $2.04 | $2.12 | 317.07K |
| Sep 23, 2026 | $2.14 | $2.17 | $2.025 | $2.06 | 435.42K |
| Sep 22, 2026 | $2.04 | $2.24 | $2.01 | $2.15 | 572.48K |
| Sep 21, 2026 | $1.89 | $2.025 | $1.8706 | $2.01 | 334K |
| Sep 18, 2026 | $1.71 | $1.8951 | $1.69 | $1.85 | 478.19K |
| Sep 17, 2026 | $1.74 | $1.77 | $1.67 | $1.70 | 463.84K |
| Sep 16, 2026 | $1.85 | $1.90 | $1.695 | $1.70 | 765.12K |
| Sep 15, 2026 | $1.97 | $1.975 | $1.805 | $1.83 | 304.88K |
| Sep 14, 2026 | $1.98 | $1.99 | $1.94 | $1.96 | 208.34K |
| Sep 11, 2026 | $2.05 | $2.06 | $1.95 | $2.00 | 461.59K |
| Sep 10, 2026 | $2.03 | $2.06 | $1.96 | $2.04 | 323.97K |
| Sep 9, 2026 | $2.10 | $2.17 | $1.99 | $1.99 | 239.12K |
Latest ACRV news
The latest Smart Investors Daily articles mentioning ACRV.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…
